Skip to main content
Signal8
Hashad Yehia profile photo

Yehia Hashad

CIK: 0001877701

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (46.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (53.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Bausch & Lomb Corp logo
BLCO

Bausch & Lomb Corp

Officer
Unity Biotechnology, Inc. logo
UBX

Unity Biotechnology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Aug 5, 2026
    Award(A)
    Direct
    21K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    May 5, 2026
    Tax Payment(F)
    Direct
    13.7K shares at avg. $16.00$219K
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 27, 2026
    Tax Payment(F)
    Direct
    11.6K shares at avg. $18.30$213K
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 27, 2026
    Tax Payment(F)
    Direct
    5.1K shares at avg. $18.30$93K
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 26, 2026
    Tax Payment(F)
    Direct
    2.2K shares at avg. $18.49$40K
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 25, 2026
    Award(A)
    Direct
    35K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 18, 2026
    Award(A)
    Direct
    29.4K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Aug 5, 2025
    Award(A)
    Direct
    17.7K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Jul 25, 2025
    Tax Payment(F)
    Direct
    2.8K shares at avg. $14.32$41K
  • Unity Biotechnology, Inc. logo
    UBX

    Unity Biotechnology, Inc.

    Mar 8, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    20K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Feb 26, 2025
    Award(A)
    Direct
    25.2K shares-
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Dec 23, 2024
    Tax Payment(F)
    Direct
    2.3K shares at avg. $17.83$41K
  • Bausch & Lomb Corp logo
    BLCO

    Bausch & Lomb Corp

    Dec 23, 2024
    Tax Payment(F)
    Direct
    2.8K shares at avg. $17.83$49K

1-13 of 13

About Hashad Yehia

Hashad Yehia (SEC CIK 0001877701) files insider reports with the SEC as EVP of R&D and CMO of Bausch & Lomb Corp (BLCO) and Director of Unity Biotechnology, Inc. (UBX).

Signal8 holds 11 ownership filings by Hashad Yehia (1 Form 3, 10 Form 4), filed between Dec 26, 2024 and Aug 7, 2026. Those filings report 13 transactions, from Dec 23, 2024 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hashad Yehia's filings is in VAUGHAN.

Recent filings by Hashad Yehia

  • Aug 5, 2026: Grant or award of BLCO shares (Form 4, code A).
  • May 5, 2026: Tax withholding of BLCO shares (Form 4, code F).
  • Feb 27, 2026: Tax withholdings of BLCO shares (2 lines, Form 4, code F).
  • Feb 26, 2026: Tax withholding of BLCO shares (Form 4, code F).
  • Feb 25, 2026: Grant or award of BLCO shares (Form 4, code A).

Other insiders filing for Bausch & Lomb Corp (BLCO)

How to read Form 4 transaction codes